NLRP3 and B-cell chronic lymphocytic leukemia: Namely, in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), Salaro et al. highlighted that NLRP3 overexpression by the neoplastic lymphocytes correlated with the inhibition of cell proliferation and induction of apoptosis, while NLRP3 downregulation contributed to lymphomagenesis [92].